Research and Development

AI-powered blood test supports risk stratification of heart disease patients

A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.

November 27, 2023

Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test

Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.

November 22, 2023

Bit.bio unveils cell therapy candidate for liver conditions

Synthetic biology company bit.bio has unveiled a lead cell therapy candidate as a treatment for life-threatening liver conditions, and it has set out its broader cell therapy pipeline.

November 22, 2023

Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution

Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.

November 20, 2023

PLK1 inhibitors show promise for inflammatory disease treatment, study shows

A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.

November 14, 2023

Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases

Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.

November 7, 2023

Pharma companies back project to create largest African ancestry genomics research database

AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.

October 25, 2023

Targeting feeder cells reverses prostate cancer’s resistance to treatment in study

Scientists have found a way to reverse prostate cancer’s resistance to drugs in research, which they say could have a broad impact across multiple cancer types.

October 24, 2023

Oxford Nanopore to receive $84.6M investment from BioMérieux, enters collaboration with Mayo Clinic

Oxford Nanopore is receiving a strategic investment of 70 million pounds ($84.6 million) from in vitro diagnostics (IVD) company BioMérieux. In addition, the firm has entered a collaboration with the Mayo Clinic on test development.

October 19, 2023

ARUP launches new collaborative research institute

ARUP Industries is hoping to “push the boundaries of diagnostic medicine” via the launch of a new research institute that aims to forge collaborations with industry and community partners.

October 18, 2023

CMS opens new doors for cell and gene therapy under Medicaid

A new Medicaid-focused Innovation Center model encourages agreements between pharmaceutical companies and states for cell and gene therapies (CGT).

October 18, 2023

AI-driven method developed to identify therapeutic targets

Researchers have developed a method of identifying therapeutic targets for human diseases associated with protein phase separation that they say could be used to discover targets for Alzheimer’s and other neurogenerative diseases.

October 17, 2023

Page 1 of 36

Next Page